English Pharmaceutical Industries products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer and contract manufacturer · Lahore · Pakistan
Lahore-based pharmaceutical manufacturer and contract manufacturer with multi-product production capabilities.
English Pharmaceutical Industries products in Pakistan
English Pharmaceutical Industries has 111 medicine presentations registered in Pakistan under 54 brands, covering 46 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Hematology & thrombosis. Its brands with the most registered strengths and packs are Enmox (Amoxicillin), Chroncef (Ceftriaxone), Engsit (Ondansetron) and Cipronag (Ciprofloxacin). 111 products have an official DRAP price on MedInfoBase. See all 54 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer and contract manufacturer
- Address
- Lahore, Pakistan
- Website
- englishpharma.co ↗
- Phone
- +92 300 8435760
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where English Pharmaceutical Industries is priced against the market
97 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Amoclav | Amoxicillin + clavulanic acid | 1 g + 200 mg | Injection | 1's | 074243 | PKR 323.83 | PKR 323.83/vial/unit | 🔒 Pharma Pro |
| Amoclav | Amoxicillin + clavulanic acid | 500 mg + 100 mg | Injection | 1's | 074244 | PKR 165.06 | PKR 165.06/vial/unit | 🔒 Pharma Pro |
| Biotic-P | Benzathine penicillin G | 1.2 MIU | Injection | 1's | 074332 | PKR 43.52 | PKR 43.52/vial/unit | 🔒 Pharma Pro |
| Biotic-P | Benzathine penicillin G | 0.6 MIU | IM injection | 1's | 074333 | PKR 29.67 | PKR 29.67/vial/unit | No comparator |
| Ciliclox | Ampicillin + Cloxacillin | 250 mg + 250 mg | Injection | 10's | 074245 | PKR 434.61 | PKR 43.46/vial/unit | 🔒 Pharma Pro |
| Ciliclox | Ampicillin + Cloxacillin | 125 mg + 125 mg | Injection | 10's | 074246 | PKR 302.34 | PKR 30.23/vial/unit | 🔒 Pharma Pro |
| Enmox | Amoxicillin | 1000 mg | Tablet | 10's | 023753 | PKR 232.16 | PKR 23.22/tablet | 🔒 Pharma Pro |
| Enmox | Amoxicillin | 125 mg/5 mL | Suspension | 60ml | 026139 | PKR 83.86 | PKR 1.40/mL | 🔒 Pharma Pro |
| Enmox | Amoxicillin | 250 mg/5 mL | Suspension | 60ml | 026140 | PKR 110.00 | PKR 1.83/mL | 🔒 Pharma Pro |
| Enmox | Amoxicillin | 500 mg | Tablet | 20's | 026141 | PKR 228.54 | PKR 11.43/tablet | 🔒 Pharma Pro |
| Enmox | Amoxicillin | 250 mg | Capsule | 100's | 065933 | PKR 649.80 | PKR 6.50/capsule | 🔒 Pharma Pro |
| Enmox | Amoxicillin | 500 mg | Capsule | 100's | 065934 | PKR 966.60 | PKR 9.67/capsule | 🔒 Pharma Pro |
| Enmox | Amoxicillin | 500 mg | Injection | 10xvial's | 074242 | PKR 647.54 | — | No comparator |
| Enmox | Amoxicillin | 250 mg | Injection | 10 x vial's | 074334 | PKR 476.13 | — | No comparator |
| Vinzat | Piperacillin + tazobactam | 2 g + 0.25 g | Injection | 1's | 064556 | PKR 691.77 | PKR 691.77/vial/unit | 🔒 Pharma Pro |
| Vinzat | Piperacillin + tazobactam | 4 g + 0.5 g | Injection | 1's | 064557 | PKR 1,424.22 | PKR 1,424.22/vial/unit | 🔒 Pharma Pro |
| Zyncilliin | Ampicillin | 250 mg | Injection | 10's | 074336 | PKR 296.67 | PKR 29.67/vial/unit | 🔒 Pharma Pro |
| Zyncillin | Ampicillin | 500 mg | Injection | 10 x vial's | 074335 | PKR 438.04 | — | No comparator |
All 54 English Pharmaceutical Industries brands in Pakistan
- Aculac Lactulose · 3.35 g syrup
- Amoclav Amoxicillin + clavulanic acid · 1 g + 200 mg injection, 500 mg + 100 mg injection
- Amsipol Paracetamol + Caffeine · 500 mg + 65 mg tablet
- Biotic-P Benzathine penicillin G · 0.6 MIU injection, 1.2 MIU injection
- Cefaz Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Chroncef Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Ciliclox Ampicillin + Cloxacillin · 125 mg + 125 mg injection, 250 mg + 250 mg injection
- Cipronag Ciprofloxacin · 200 mg infusion, 250 mg tablet, 500 mg tablet
- Colaite Colistimethate sodium · 1 MIU injection
- Coliate Colistimethate sodium · 2 MIU (≈68 mg colistin base activity) injection, 4.5 MIU (≈150 mg colistin base activity) injection
- E-Cip Ciprofloxacin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- E-Lev Levofloxacin · 250 mg capsule, 500 mg capsule
- Eaxiron Cefotaxime · 0.25 g injection, 0.5 g injection, 1 g injection
- Ekacin Amikacin · 100 mg injection, 250 mg injection, 50 mg injection
- Eloglipten Metformin · 500 mg tablet
- Encogyl Metronidazole · 500 mg injection
- Enfal Cefazolin · 1 g injection, 250 mg injection, 500 mg injection
- Engmox Moxifloxacin · 400 mg tablet
- Engpan Meropenem · 500 mg injection
- Engsit Ondansetron · 4 g/2 mL injection, 4 mg tablet, 4 mg/5 mL syrup
- Engsol Sodium chloride · 0.9 % injection
- Engsol W/V Sodium chloride · 0.9 % injection
- Engsunate Artesunate · 120 mg injection, 30 mg injection
- Enmox Amoxicillin · 1000 mg tablet, 125 mg/5 mL suspension, 250 mg injection
- Entum Artemether + Lumefantrine, Artemether · 20 mg + 120 mg capsule, 80 mg injection
- Entum DS Artemether + Lumefantrine · 80 mg + 480 mg tablet
- Enxamin Tranexamic acid · 250 mg injection, 500 mg injection
- Enzoxen Azithromycin · 250 mg capsule
- Erozac Fluoxetine · 20 mg capsule
- Etar Atorvastatin · 10 mg tablet, 20 mg tablet
- Hyquine Hydroxychloroquine · 200 mg tablet
- I-Folic Iron polymaltose complex + Folic acid · 100 mg elemental iron + 0.35 mg folic acid tablet
- Iron PS Iron protein succinylate · 800 mg syrup
- Klavor Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Levlong Levofloxacin · 250 mg tablet, 500 mg tablet
- Loprid Clopidogrel + Aspirin · 75 mg + 150 mg tablet
- O-Lex Omeprazole · 20 mg tablet
- Panam Paracetamol · 120 mg/5 mL suspension
- Panam Plus Paracetamol + Aspirin · 200 mg + 300 mg tablet, 300 mg + 200 mg tablet
- Premo Metoclopramide · 10 mg injection
- Roliep Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Vancotic Vancomycin · 1 g injection, 500 mg injection
- Vigilant Itraconazole · 100 mg capsule
- Vinzat Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
- Vit k1 Phytomenadione · 2 mg injection
- Vit-K1 Phytomenadione · 10 mg/mL injection
- Vitaferol Cholecalciferol · 200000 IU injection
- Water for Injection Water for Injection · 10 mL injection, 5 mL injection
- Xim Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- Xim DS Cefixime · 200 mg/5 mL suspension
- Zanzia Olanzapine · 10 mg injection
- Zolat Omeprazole · 20 mg capsule, 40 mg injection
- Zyncilliin Ampicillin · 250 mg injection
- Zyncillin Ampicillin · 500 mg injection
English Pharmaceutical Industries: common questions
How many products does English Pharmaceutical Industries have in Pakistan?
English Pharmaceutical Industries has 111 registered medicine presentations in Pakistan, sold under 54 brands and covering 46 generic medicines.
What are the main brands of English Pharmaceutical Industries?
By number of registered strengths and packs, its largest brands are Enmox (Amoxicillin), Chroncef (Ceftriaxone), Engsit (Ondansetron), Cipronag (Ciprofloxacin) and E-Cip (Ciprofloxacin). This is not a sales ranking.
Which therapy areas does English Pharmaceutical Industries cover?
The most products are in Anti-infectives (76), Gastrointestinal & hepatology (12), Hematology & thrombosis (5), Vitamins, minerals & nutrition (5) and Pain & musculoskeletal (4).
Where can I see English Pharmaceutical Industries medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.